Portfolio Holdings Detail for ISIN IE00BKM4H197
Stock Name / FundiShares MSCI EM Consumer Growth UCITS ETF
IssuerBlackrock
Entity holding fund iShares V Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF TickerCEMG.AS(EUR) CXE
ETF TickerCEMG(EUR) Euronext Amsterdam

Holdings detail for BMRN

Stock NameBiomarin Pharmaceutical Inc
TickerBMRN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS09061G1013
LEINSLL8ITTRR0J5HEMR848

Show aggregate BMRN holdings

News associated with BMRN

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives $94.00 Consensus Target Price from Brokerages
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) has earned an average rating of “Moderate Buy” from the twenty-four ratings firms that are presently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a hold rating and seventeen have issued a buy rating on the company. The average 12-month target price […] - 2025-04-02 05:35:01
Korea Investment CORP Purchases 131,600 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Korea Investment CORP grew its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 362.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 167,903 shares of the biotechnology company’s stock after purchasing an additional 131,600 shares during the quarter. Korea […] - 2025-03-31 08:45:10
Traders Purchase High Volume of Call Options on BioMarin Pharmaceutical (NASDAQ:BMRN)
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) was the target of some unusual options trading on Thursday. Traders bought 5,111 call options on the company. This represents an increase of 273% compared to the typical volume of 1,372 call options. Analyst Ratings Changes BMRN has been the subject of several recent analyst reports. Wedbush […] - 2025-03-28 07:07:10
5 Historically Cheap Growth Stocks to Buy With Confidence in the Wake of the Nasdaq Correction
Every so often, Wall Street sends a not-so-subtle reminder to investors that stocks can move in both directions. - 2025-03-27 09:06:00
Natixis Advisors LLC Purchases Shares of 19,738 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Natixis Advisors LLC acquired a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 19,738 shares of the biotechnology company’s stock, valued at approximately $1,297,000. A number of other institutional investors and hedge […] - 2025-03-26 07:50:56
EverSource Wealth Advisors LLC Sells 6,469 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
EverSource Wealth Advisors LLC lowered its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 91.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 634 shares of the biotechnology company’s stock after selling 6,469 shares during the quarter. EverSource Wealth Advisors […] - 2025-03-21 08:25:03
BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Rating Upgraded by StockNews.com
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Tuesday. BMRN has been the subject of several other research reports. Oppenheimer upgraded shares of BioMarin Pharmaceutical from a “market perform” rating to an “outperform” rating […] - 2025-03-18 06:12:54
How The Pieces Add Up: FBT Targets $219
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-17 11:50:34
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Acquired by M&T Bank Corp
M&T Bank Corp lifted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 9.5% during the fourth quarter, HoldingsChannel.com reports. The firm owned 7,085 shares of the biotechnology company’s stock after purchasing an additional 616 shares during the period. M&T Bank Corp’s holdings in BioMarin Pharmaceutical were worth $466,000 at the […] - 2025-03-14 08:08:58
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twenty-four brokerages that are presently covering the stock, MarketBeat reports. Seven analysts have rated the stock with a hold recommendation and seventeen have issued a buy recommendation on the company. The average 12-month price […] - 2025-03-05 07:12:53
Y Intercept Hong Kong Ltd Has $310,000 Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Y Intercept Hong Kong Ltd lowered its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 83.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,711 shares of the biotechnology company’s stock after selling 23,519 shares during the quarter. […] - 2025-03-04 09:05:03
Sanctuary Advisors LLC Trims Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Sanctuary Advisors LLC lowered its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 76.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,045 shares of the biotechnology company’s stock after selling 16,288 shares during the quarter. Sanctuary […] - 2025-03-04 08:22:48
New York State Common Retirement Fund Sells 4,600 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
New York State Common Retirement Fund reduced its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 4.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 93,645 shares of the biotechnology company’s stock after selling 4,600 shares during […] - 2025-02-28 09:04:56
Principal Securities Inc. Acquires 339 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Principal Securities Inc. boosted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 24.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,749 shares of the biotechnology company’s stock after buying an additional 339 shares […] - 2025-02-26 10:10:52
Asset Management One Co. Ltd. Boosts Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Asset Management One Co. Ltd. raised its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 76,785 shares of the biotechnology company’s stock after acquiring an additional 283 shares during the period. Asset Management One Co. Ltd.’s holdings in BioMarin Pharmaceutical were worth […] - 2025-02-19 10:44:54
Rhumbline Advisers Has $36.56 Million Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Rhumbline Advisers boosted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 2.0% in the fourth quarter, Holdings Channel reports. The firm owned 556,255 shares of the biotechnology company’s stock after purchasing an additional 11,025 shares during the quarter. Rhumbline Advisers’ holdings in BioMarin Pharmaceutical were worth $36,563,000 as of its most recent […] - 2025-02-19 09:03:32
Entropy Technologies LP Invests $500,000 in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Entropy Technologies LP acquired a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 7,604 shares of the biotechnology company’s stock, valued at approximately $500,000. Other large […] - 2025-02-13 10:12:51
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stock Holdings Trimmed by State of Alaska Department of Revenue
State of Alaska Department of Revenue cut its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 25.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 21,730 shares of the biotechnology company’s stock after selling 7,495 shares during the quarter. State […] - 2025-02-13 09:38:52
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Holdings Decreased by Janney Montgomery Scott LLC
Janney Montgomery Scott LLC trimmed its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 34.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,671 shares of the biotechnology company’s stock after selling 4,029 shares during the quarter. Janney Montgomery Scott LLC’s […] - 2025-02-10 18:10:54
Robeco Institutional Asset Management B.V. Trims Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Robeco Institutional Asset Management B.V. cut its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 58.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 86,574 shares of the biotechnology company’s stock after selling 124,092 shares during the […] - 2025-02-03 08:57:17

iShares MSCI EM Consumer Growth UCITS ETF BMRN holdings

DateNumber of BMRN Shares HeldBase Market Value of BMRN SharesLocal Market Value of BMRN SharesChange in BMRN Shares HeldChange in BMRN Base ValueCurrent Price per BMRN Share HeldPrevious Price per BMRN Share Held
2025-04-02 (Wednesday)1,155USD 78,910BMRN holding increased by 439USD 78,9100USD 439 USD 68.3203 USD 67.9403
2025-04-01 (Tuesday)1,155USD 78,471BMRN holding decreased by -3176USD 78,4710USD -3,176 USD 67.9403 USD 70.69
2025-03-31 (Monday)1,155USD 81,647BMRN holding decreased by -866USD 81,6470USD -866 USD 70.69 USD 71.4398
2025-03-28 (Friday)1,155USD 82,513BMRN holding decreased by -1606USD 82,5130USD -1,606 USD 71.4398 USD 72.8303
2025-03-27 (Thursday)1,155USD 84,119BMRN holding increased by 1560USD 84,1190USD 1,560 USD 72.8303 USD 71.4797
2025-03-26 (Wednesday)1,155USD 82,559BMRN holding decreased by -58USD 82,5590USD -58 USD 71.4797 USD 71.5299
2025-03-25 (Tuesday)1,155USD 82,617BMRN holding decreased by -531USD 82,6170USD -531 USD 71.5299 USD 71.9896
2025-03-24 (Monday)1,155USD 83,148BMRN holding increased by 866USD 83,1480USD 866 USD 71.9896 USD 71.2398
2025-03-21 (Friday)1,155USD 82,282BMRN holding decreased by -416USD 82,2820USD -416 USD 71.2398 USD 71.6
2025-03-20 (Thursday)1,155USD 82,698BMRN holding increased by 323USD 82,6980USD 323 USD 71.6 USD 71.3203
2025-03-19 (Wednesday)1,155USD 82,375BMRN holding decreased by -231USD 82,3750USD -231 USD 71.3203 USD 71.5203
2025-03-18 (Tuesday)1,155USD 82,606BMRN holding decreased by -34USD 82,6060USD -34 USD 71.5203 USD 71.5498
2025-03-17 (Monday)1,155USD 82,640BMRN holding increased by 2437USD 82,6400USD 2,437 USD 71.5498 USD 69.4398
2025-03-14 (Friday)1,155USD 80,203BMRN holding decreased by -1340USD 80,2030USD -1,340 USD 69.4398 USD 70.6
2025-03-13 (Thursday)1,155BMRN holding decreased by -56USD 81,543BMRN holding decreased by -3881USD 81,543-56USD -3,881 USD 70.6 USD 70.54
2025-03-12 (Wednesday)1,211USD 85,424BMRN holding increased by 61USD 85,4240USD 61 USD 70.54 USD 70.4897
2025-03-11 (Tuesday)1,211USD 85,363BMRN holding decreased by -1865USD 85,3630USD -1,865 USD 70.4897 USD 72.0297
2025-03-10 (Monday)1,211USD 87,228BMRN holding decreased by -243USD 87,2280USD -243 USD 72.0297 USD 72.2304
2025-03-07 (Friday)1,211USD 87,471BMRN holding increased by 1236USD 87,4710USD 1,236 USD 72.2304 USD 71.2097
2025-03-06 (Thursday)1,211USD 86,235BMRN holding increased by 24USD 86,2350USD 24 USD 71.2097 USD 71.1899
2025-03-05 (Wednesday)1,211USD 86,211USD 86,211
2024-11-12 (Tuesday)1,818USD 120,224USD 120,224
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of BMRN by Blackrock for IE00BKM4H197

Show aggregate share trades of BMRN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-03-13SELL-56 70.600* 71.30 Profit of 3,993 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of BMRN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-04-03193,0950648,10229.8%
2025-04-02121,2150542,09222.4%
2025-04-01115,3250427,65527.0%
2025-03-31251,24513,914455,63955.1%
2025-03-28190,5590493,39138.6%
2025-03-27260,5180547,81347.6%
2025-03-26244,0452,886546,38544.7%
2025-03-25111,9931,199292,46038.3%
2025-03-24104,07842304,11934.2%
2025-03-21391,71030553,99970.7%
2025-03-20183,80611,851323,57956.8%
2025-03-19169,649992366,33946.3%
2025-03-18146,912131376,15439.1%
2025-03-17110,7032,527311,88135.5%
2025-03-14262,7882,376450,08058.4%
2025-03-13119,0661258,14646.1%
2025-03-12139,64712,744389,91035.8%
2025-03-11162,058891348,82846.5%
2025-03-10212,2251,129531,13140.0%
2025-03-07348,9326,231608,06457.4%
2025-03-06201,2865,695416,50048.3%
2025-03-05451,714145648,10269.7%
2025-03-04327,723112588,40355.7%
2025-03-03291,15870667,73243.6%
2025-02-28132,406232309,83442.7%
2025-02-27177,38358434,40340.8%
2025-02-26146,47256453,69132.3%
2025-02-25437,6601,307934,64746.8%
2025-02-24255,346129591,16343.2%
2025-02-21337,804143915,83336.9%
2025-02-20655,432251,999,28332.8%
2025-02-19212,708412524,70540.5%
2025-02-18152,963123346,36044.2%
2025-02-14148,4450371,19340.0%
2025-02-13229,1670493,14546.5%
2025-02-12198,705169410,75848.4%
2025-02-11122,897108308,94639.8%
2025-02-10106,352275250,27442.5%
2025-02-07154,723139286,35754.0%
2025-02-06170,6510414,10541.2%
2025-02-05113,6030363,14531.3%
2025-02-04114,3470368,80431.0%
2025-02-03137,5240343,52340.0%
2025-01-31166,1021310,76053.5%
2025-01-30148,8770369,10040.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.